Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Fruit/Vegetable Drinks on the Human Intestine

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-50 years of age at screen~2. Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.~Exclusion Criteria:~1. Any subject with a history of diabetes mellitus on medications, hyperlipidemia on medications, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP\>160mmHg, diastolic BP\>95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history or routine physical examination.~2. Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.~3. Any subject who currently uses tobacco products.~4. Any history of gastrointestinal disease except for appendectomy~5. No antibiotics or laxatives use during the 2 months before the study.~6. Any allergies to nuts~7. Any subject who is unable or unwilling to comply with the study protocol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- pressed juice 6 bottles (Type: OTHER): Subjects will consume pressed juice daily for 3 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).